{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:16:42Z","timestamp":1793395002000,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2007,11,9]],"date-time":"2007-11-09T00:00:00Z","timestamp":1194566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s00415-007-0611-y","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T19:26:17Z","timestamp":1194463577000},"page":"1676-1683","source":"Crossref","is-referenced-by-count":171,"title":["Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington\u2019s disease gene carriers and healthy subjects"],"prefix":"10.1007","volume":"254","author":[{"given":"N.","family":"Klepac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Relja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Klepac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"He\u0107imovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Babi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Trkulja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,9]]},"reference":[{"key":"611_CR1","first-page":"133","volume":"59","author":"Albers","year":"2000","unstructured":"Albers DS, Beal MF (2000) Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J Neural Transm 59:133\u2013154","journal-title":"J Neural Transm"},{"key":"611_CR2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nrn1434","volume":"10","author":"Andersen","year":"2004","unstructured":"Andersen JK (2004) Oxidative stress in neurodegeneration: cause or consequence? Nat Med 10:18\u201325","journal-title":"Nat Med"},{"key":"611_CR3","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","volume":"361","author":"Bates","year":"2003","unstructured":"Bates G (2003) Huntingtin aggregation and toxicity in Huntington's disease. Lancet 361:1642\u20131644","journal-title":"Lancet"},{"key":"611_CR4","first-page":"1","volume":"7","author":"Beal","year":"2000","unstructured":"Beal MF (2000) Mechanisms of cell death in neurodegenerative disorders. Eur J Neurol 7 (Suppl. 2):1\u20134","journal-title":"Eur J Neurol"},{"key":"611_CR5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1750-3639.1999.tb00216.x","volume":"9","author":"Browne","year":"1999","unstructured":"Browne SE, Ferrante RJ, Beal MF (1999) Oxidative stress in Huntington's disease. Brain Pathol 9:147\u2013163","journal-title":"Brain Pathol"},{"key":"611_CR6","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","volume":"95","author":"Brouillet","year":"2005","unstructured":"Brouillet E, Jacquard C, Bizat N, Blum D (2005) 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J Neurochem 95:1521\u20131540","journal-title":"J Neurochem"},{"key":"611_CR7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0047-6374(01)00249-4","volume":"122","author":"Butterfield","year":"2001","unstructured":"Butterfield DA,Kanski J (2001) Brain protein oxidation in age-related neurodegenerative disorder that are associated with aggregated proteins. Mech Ageing Dev 122:945\u2013962","journal-title":"Mech Ageing Dev"},{"key":"611_CR8","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/j.1471-4159.2006.03807.x","volume":"97","author":"Christofiades","year":"2006","unstructured":"Christofiades J, Bridel M, Egerton M, Mackay GM, Forrest CM, Stoy N, Darlington LG, Stone TW (2006) Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury. J Neurochem 97:1078\u20131088","journal-title":"J Neurochem"},{"key":"611_CR9","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archneur.57.9.1265","volume":"57","author":"Delanty","year":"2000","unstructured":"Delanty N, Dichter MA (2000) Antioxidant therapy in neurological diseases. Arch Neurol 57:1265\u20131270","journal-title":"Arch Neurol"},{"key":"611_CR10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/BC.2003.059","volume":"384","author":"Dringen","year":"2003","unstructured":"Dringen R,Hirrlinger J (2003) Glutathione pathways in the brain. Biol Chem 384:505\u2013516","journal-title":"Biol Chem"},{"key":"611_CR11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00019052-200208000-00013","volume":"15","author":"Feigin","year":"2002","unstructured":"Feigin A, Zgaljardic D (2002) Recent advances in Huntington's disease: implications for experimental therapeutics. Curr Opin Neurol 15:483\u2013489","journal-title":"Curr Opin Neurol"},{"key":"611_CR12","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1136\/jnnp.2004.060186","volume":"76","author":"Hague","year":"2005","unstructured":"Hague SM,Klaffke S, Bandmann O (2005) Neurodegenerative disorders: Parkinson's disease and Huntington's disease. J Neurol Neurosurg Psychiatry 76:1058\u20131063","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"611_CR13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/humu.9055","volume":"20","author":"He\u0107imovi\u0107","year":"2002","unstructured":"He\u0107imovi\u0107 S, Klepac N, Vla\u0161i\u0107 J,Vojta A, Janko D, \u0160karpa-Prpi\u0107 I, Canki- Klain N,Markovi\u0107 D, Bo\u017eikov J, Relja M, Paveli\u0107 K (2002) Genetic background of Huntington disease in Croatia:Molecular analysis of CAG, CCG, and Delta2642 (E2642del) polymorphisms. Hum Mutat 20:233","journal-title":"Hum Mutat"},{"key":"611_CR14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s11064-006-9110-2","volume":"31","author":"del Hoyo","year":"2006","unstructured":"del Hoyo P, Garcia-Redondo A, de Bustos F,Molina JA, Sayed Y, Alonso-Navarro H, Caballero L, Arenas J, Jimenez-Jimenez FJ (2006) Oxidative stress in skin fibroblasts cultures of patients with Huntington's disease. Neurochem Res 31:1103\u20131109","journal-title":"Neurochem Res"},{"key":"611_CR15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"Huntington","year":"1993","unstructured":"Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosome. Cell 72: 971\u2013983","journal-title":"Cell"},{"key":"611_CR16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington","year":"1996","unstructured":"Huntington Study Group (1996) Unified Huntington's disease rating scale: reliability and consistency. Mov Disord 11:136\u2013142","journal-title":"Mov Disord"},{"key":"611_CR17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0076-6879(94)34103-6","volume":"56","author":"Inoue","year":"1994","unstructured":"Inoue M, Koyama K (1994) Determination of superoxide and vitamine C radicals using cytochrome c and superoxide dismutase derivatives. Methods Enzymol 56:338\u2013343","journal-title":"Methods Enzymol"},{"key":"611_CR18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0003-2697(88)90554-4","volume":"174","author":"Johansson","year":"1988","unstructured":"Johansson LH, Borg LA (1988) A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem 174:331\u2013336","journal-title":"Anal Biochem"},{"key":"611_CR19","first-page":"720","volume":"20","author":"Lang","year":"1992","unstructured":"Lang C,Naryshin S, Schneider DL, Mills BJ, Linderman RD (1992) Low blood glutathione levels in healthy aging adult. J Lab Clin Med 20:720\u2013725","journal-title":"J Lab Clin Med"},{"key":"611_CR20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0076-6879(90)86141-H","volume":"186","author":"Levine","year":"1990","unstructured":"Levine RL, Gardland D, Olivier CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464\u2013478","journal-title":"Methods Enzymol"},{"key":"611_CR21","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall LJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:263\u2013275","journal-title":"J Biol Chem"},{"key":"611_CR22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2005.04.023","volume":"827","author":"Mariani","year":"2005","unstructured":"Mariani E, Polidori MC, Cherubini A, Mecocci P (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci 827:65\u201375","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"611_CR23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","volume":"47","author":"Marklund","year":"1974","unstructured":"Marklund S,Marklund G (1974) Involvement of the superoxide anion radical in the antioxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469\u2013474","journal-title":"Eur J Biochem"},{"key":"611_CR24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1602\/neurorx.1.2.255","volume":"1","author":"Myers","year":"2004","unstructured":"Myers RH (2004) Huntington's disease genetics. NeuroRx 1:255\u2013262","journal-title":"NeuroRx"},{"key":"611_CR25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"Ohkawa","year":"1979","unstructured":"Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxidases in animal tissue by thiobarbituric acid reaction. Annal Biochem 95:351\u2013358","journal-title":"Annal Biochem"},{"key":"611_CR26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0006-8993(00)02082-5","volume":"862","author":"Perez-Severiano","year":"2000","unstructured":"Perez-Severiano F, Rios C, Segovia J (2000) Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease. Brain Res 862:234\u2013237","journal-title":"Brain Res"},{"key":"611_CR27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1010911417383","volume":"26","author":"Santamaria","year":"2001","unstructured":"Santamaria A, Perez-Severiano F, Rodriquez-Martinez E, Maldonado PD, Pedraza-Chaverri J, Rios C, Segovia J (2001) Comparative analysis of superoxide dismutase activity between acute pharmacological models and transgenic mouse model of Huntington's disease. Neurchem Res 26:419\u2013424","journal-title":"Neurchem Res"},{"key":"611_CR28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","volume":"36","author":"Sian","year":"1994","unstructured":"Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P,Marsden CD (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36:348\u2013355","journal-title":"Ann Neurol"},{"key":"611_CR29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","volume":"93","author":"Stoy","year":"2005","unstructured":"Stoy N, Mackay GM, Forrest CM, Christofides J, Egerton M, Stone TW, Darlington LG (2005) Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J Neurochem 93:611\u2013623","journal-title":"J Neurochem"},{"key":"611_CR30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainresbull.2005.06.024","volume":"67","author":"Taiq","year":"2005","unstructured":"Taiq M, Khan HA, Elfaki I, Al Deeb S, Al Moutaery K (2005) Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats. Brain Res Bull 67:161\u2013168","journal-title":"Brain Res Bull"},{"key":"611_CR31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/hh1501.094365","volume":"89","author":"Tarpey","year":"2001","unstructured":"Tarpey MM; Fridovich I (2001) Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide and peroxynitrite. Circ Res 89:224\u2013236","journal-title":"Circ Res"},{"key":"611_CR32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/mcpr.1993.1034","volume":"7","author":"Warner","year":"1993","unstructured":"Warner JP, Barron LH, Brock DJH (1993) A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Molecular Cellular Probes 7:235\u2013239","journal-title":"Molecular Cellular Probes"},{"key":"611_CR33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.neuro.23.1.217","volume":"23","author":"Zoghbi","year":"2000","unstructured":"Zoghbi HY, Orr HT (2000) Glutamine repeats and neurodegeneration. Annu Rev Neurosci 23:217\u2013247","journal-title":"Annu Rev Neurosci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-007-0611-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-007-0611-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-007-0611-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T03:04:41Z","timestamp":1630033481000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-007-0611-y"}},"subtitle":["A cross-sectional study"],"short-title":[],"issued":{"date-parts":[[2007,11,9]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["611"],"URL":"https:\/\/doi.org\/10.1007\/s00415-007-0611-y","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,9]]}}}